CAS 885434-70-8

HJC0350

CAS: 885434-70-8

HJC0350

Purity: ≥98%

Molecular weight: 277.38g/mol

Ref: 54-BUP13464

HJC0350

CAS: 885434-70-8

HJC0350 is an effective and specific EPAC2 inhibitor (IC50: 0.3 μM), and no inhibition of Epac1.

Formula: C₁₅H₁₉NO₂S

Purity: 99.27% - 99.65%

Color and Shape: Solid

Molecular weight: 277.38

Ref: TM-T6536

1-(Mesitylsulfonyl)-2,4-dimethyl-1H-pyrrole

CAS: 885434-70-8

Formula: C₁₅H₁₉NO₂S

Purity: 99%

Molecular weight: 277.38

Ref: 10-F540361

HJC0350

CAS: 885434-70-8

HJC0350 is a novel compound that has been shown to be effective in treating diabetic neuropathy. HJC0350 is a small molecule that modulates intracellular calcium ion levels and activates the redox signal, which plays an important role in energy metabolism. This compound can also be used in cancer research as it has been shown to inhibit tumor growth by blocking the cation channels of cancer cells. It can also be used to treat bladder cancer by inhibiting the production of antimicrobial peptides and forskolin, a cyclic adenosine monophosphate (cAMP) analog. HJC0350 has also been shown to have anti-inflammatory effects and may be useful for treating cardiac diseases such as heart attack or congestive heart failure.

Formula: C₁₅H₁₉NO₂S

Purity: Min. 95%

Molecular weight: 277.38 g/mol

Ref: 3D-KKB43470